U.S. markets open in 1 hour 54 minutes
  • S&P Futures

    3,634.50
    +1.75 (+0.05%)
     
  • Dow Futures

    29,975.00
    -23.00 (-0.08%)
     
  • Nasdaq Futures

    12,117.50
    +41.50 (+0.34%)
     
  • Russell 2000 Futures

    1,847.60
    -3.90 (-0.21%)
     
  • Crude Oil

    45.25
    +0.34 (+0.76%)
     
  • Gold

    1,810.90
    +6.30 (+0.35%)
     
  • Silver

    23.41
    +0.11 (+0.45%)
     
  • EUR/USD

    1.1892
    -0.0004 (-0.04%)
     
  • 10-Yr Bond

    0.8820
    0.0000 (0.00%)
     
  • Vix

    22.00
    -0.66 (-2.91%)
     
  • GBP/USD

    1.3347
    -0.0011 (-0.08%)
     
  • USD/JPY

    104.4520
    -0.0280 (-0.03%)
     
  • BTC-USD

    19,213.51
    -53.14 (-0.28%)
     
  • CMC Crypto 200

    381.28
    +11.52 (+3.12%)
     
  • FTSE 100

    6,387.63
    -44.54 (-0.69%)
     
  • Nikkei 225

    26,296.86
    +131.27 (+0.50%)
     

Kindred Bio: 3Q Earnings Snapshot

·1 min read

BURLINGAME, Calif. (AP) _ Kindred Biosciences Inc. (KIN) on Monday reported a loss of $12.2 million in its third quarter.

The Burlingame, California-based company said it had a loss of 31 cents per share.

The biopharmaceutical company posted revenue of $1 million in the period.

In the final minutes of trading on Monday, the company's shares hit $3.77. A year ago, they were trading at $8.70.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KIN at https://www.zacks.com/ap/KIN